TFP
GH icon

Tilia Fiduciary Partners’s Guardant Health GH Stock Holding History

Tilia Fiduciary Partners’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-42
Closed -$4K – 545
2021
Q4 		$4K Buy
+42
New +$4.34K ﹤0.01% 499

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Tilia Fiduciary Partners's GH Position: Q1 2022 in Review

Tilia Fiduciary Partners sold out of Guardant Health (GH) in Q1 2022, closing a stake of 42 shares — an estimated $4K sold.

Tilia Fiduciary Partners first reported a position in GH in Q4 2021 and held it in 1 quarter. The position peaked at $4K in Q4 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • Tilia Fiduciary Partners reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 42 Guardant Health shares in Q1 2022, an estimated $4K.
  • Tilia Fiduciary Partners first reported a position in Guardant Health in Q4 2021 and held it in 1 quarter.
  • Tilia Fiduciary Partners's Guardant Health position peaked at $4K in Q4 2021.
  • 356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Tilia Fiduciary Partners's 13F filing for Q1 2022, filed 18 Apr 2022.